Supernus Pharmaceuticals SUPN
NASDAQ SUPN
$42.11 -0.07 (-0.17%)
As of: Oct 2, 2026 · 1:24 PM EDT

Supernus Pharmaceuticals (SUPN) Depreciation & Amortization (CF) (2011 - 2026)

Updated

Supernus Pharmaceuticals' Depreciation & Amortization (CF) was $25.75 million in Q2 2026, up 20.5% from $21.36 million a year earlier but down 1.5% from the prior quarter.

Analysis

Supernus Pharmaceuticals (SUPN) Depreciation & Amortization (CF) (2011 - 2026) Analysis & Trends

On a trailing twelve-month basis, Supernus Pharmaceuticals' Depreciation & Amortization (CF) was $101.7 million through Jun 30, 2026, up 26.0% year-over-year; for FY2025, it came in at $91.56 million, up 13.9% from FY2024.

  • Depreciation & Amortization (CF) shows a five-year compound annual growth rate of 38.2% (FY2020 to FY2025).
  • In earlier years, Depreciation & Amortization (CF) was $80.41 million in FY2024 (-5.2%), $84.86 million in FY2023 (-0.8%), $85.54 million in FY2022 (+162.4%) and $32.6 million in FY2021 (+79.7%).
  • Quarterly Depreciation & Amortization (CF) has moved between $6.68 million (Q3 2021) and $26.13 million (Q1 2026) over five years.
  • Compared with a year earlier, Depreciation & Amortization (CF) has increased for five straight quarters, with growth averaging 10.6% over the last eight quarters.
  • The best year-over-year quarter for Depreciation & Amortization (CF) over five years was Q3 2022 (growth of 226.2%); the worst was Q3 2021 (a decline of 14.9%).
  • Per Business Quant data, SUPN's Depreciation & Amortization (CF) in the three quarters before Q2 2026 was $26.13 million (Q1 2026), $25.02 million (Q4 2025) and $24.81 million (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Dep. & Amort. (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 1.96 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 194.00 Mn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 599.00 Mn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn -
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn 1.93 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 1.11 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 98.00 Mn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 1.62 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 56.50 Mn
10 Supernus Pharmaceuticals 2.50 Bn 1.16 Bn 185.39 Mn 25.75 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 25.75 Mn
Mar 31, 2026 26.13 Mn
Dec 31, 2025 25.02 Mn
Sep 30, 2025 24.81 Mn
Jun 30, 2025 21.36 Mn
Mar 31, 2025 20.38 Mn
Dec 31, 2024 18.85 Mn
Sep 30, 2024 20.10 Mn
Jun 30, 2024 20.72 Mn
Mar 31, 2024 20.75 Mn
Dec 31, 2023 21.68 Mn
Sep 30, 2023 21.86 Mn
Jun 30, 2023 20.73 Mn
Mar 31, 2023 20.60 Mn
Dec 31, 2022 20.85 Mn
Sep 30, 2022 21.78 Mn
Jun 30, 2022 21.56 Mn
Mar 31, 2022 21.36 Mn
Dec 31, 2021 12.71 Mn
Sep 30, 2021 6.68 Mn
API Access

Supernus Pharmaceuticals Depreciation & Amortization (CF) API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=depreciation-and-amortization-cf&ticker=SUPN&period=max&api_key=YOUR_API_KEY